TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET
Martha W. den Hollander(University of Groningen), Annemiek Walenkamp(University Medical Center Groningen)
Cited by 99
Related Papers
Defining EGFR amplification status for clinical trial inclusion
|Neuro-Oncology|2019|44
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
|European Journal of Nuclear Medicine and Molecular Imaging|2011|42
Neuroendocrine tumours and their microenvironment
|Cancer Immunology Immunotherapy|2020|26